Two Sigma Securities LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,083 shares of the conglomerate’s stock, valued at approximately $778,000.
A number of other hedge funds also recently added to or reduced their stakes in DHR. Main Street Group LTD purchased a new stake in shares of Danaher during the first quarter worth $25,000. N.E.W. Advisory Services LLC purchased a new position in Danaher in the second quarter valued at $25,000. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC purchased a new stake in Danaher during the 2nd quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher during the 4th quarter worth about $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Stock Performance
Shares of Danaher stock opened at $206.89 on Wednesday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm’s 50 day moving average is $200.73 and its two-hundred day moving average is $192.22. The firm has a market capitalization of $145.44 billion, a P/E ratio of 36.75, a P/E/G ratio of 2.66 and a beta of 0.78.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on DHR. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Stifel Nicolaus reduced their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Evercore reiterated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. Finally, Citigroup assumed coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $228.91.
Check Out Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
